|
1
|
Felson DT: Clinical practice.
Osteoarthritis of the knee. N Engl J Med. 354:841–848. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang W, Nuki G, Moskowitz RW, et al:
OARSI recommendations for the management of hip and knee
osteoarthritis: part III: Changes in evidence following systematic
cumulative update of research published through January 2009.
Osteoarthritis Cartilage. 18:476–499. 2010. View Article : Google Scholar
|
|
3
|
Qiu G: Osteoarthritis diagnosis and
treatment guidelines. Chinese J Joint Surgery. 1:281–285. 2007.
|
|
4
|
Shortkroff S and Yates KE: Alteration of
matrix glycosaminoglycans diminishes articular chondrocytes’
response to a canonical Wnt signal. Osteoarthritis Cartilage.
15:147–154. 2007.PubMed/NCBI
|
|
5
|
Chan BY, Fuller ES, Russell AK, et al:
Increased chondrocyte sclerostin may protect against cartilage
degradation in osteoarthritis. Osteoarthritis Cartilage.
19:874–885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang JG, Xia C, Zheng XP, et al:
17β-Estradiol promotes cell proliferation in rat osteoarthritis
model chondrocytes via PI3K/Akt pathway. Cell Mol Biol Lett.
16:564–575. 2011.
|
|
7
|
Kashiwagi A, Schipani E, Fein MJ, Greer PA
and Shimada M: Targeted deletion of Capn4 in cells of the
chondrocyte lineage impairs chondrocyte proliferation and
differentiation. Mol Cell Biol. 30:2799–2810. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sarzi-Puttini P, Cimmino MA, Scarpa R, et
al: Osteoarthritis: an overview of the disease and its treatment
strategies. Semin Arthritis Rheum. 35(Suppl 1): 1–10. 2005.
View Article : Google Scholar
|
|
9
|
Badley EM, Rasooly I and Webster GK:
Relative importance of musculoskeletal disorders as a cause of
chronic health problems, disability, and health care utilization:
findings from the 1990 Ontario Health Survey. J Rheumatol.
21:505–514. 1994.
|
|
10
|
Felson DT, Lawrence RC, Dieppe PA, et al:
Osteoarthritis: new insights. Part 1: the disease and its risk
factors. Ann Intern Med. 133:635–646. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bradley JD, Brandt KD, Katz BP, Kalasinski
LA and Ryan SI: Comparison of an antiinflammatory dose of
ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the
treatment of patients with osteoarthritis of the knee. N Engl J
Med. 325:87–91. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lohmander LS, Dalén N, Englund G, et al:
Intra-articular hyaluronan injections in the treatment of
osteoarthritis of the knee: a randomised, double blind, placebo
controlled multicentre trial. Ann Rheum Dis. 55:424–431. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Berenbaum F: New horizons and perspectives
in the treatment of osteoarthritis. Arthritis Res Ther. 10(Suppl
2): S12008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahmed S, Anuntiyo J, Malemud CJ and Haqqi
TM: Biological basis for the use of botanicals in osteoarthritis
and rheumatoid arthritis: a review. Evid Based Complement Alternat
Med. 2:301–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Parkman CA: Alternative therapies for
osteoarthritis. Case Manager. 12:34–36. 2001. View Article : Google Scholar
|
|
16
|
Teekachunhatean S, Kunanusorn P,
Rojanasthien N, et al: Chinese herbal recipe versus diclofenac in
symptomatic treatment of osteoarthritis of the knee: a randomized
controlled trial [ISRCTN70292892]. BMC Complement Altern Med.
4:192004.PubMed/NCBI
|
|
17
|
Setty AR and Sigal LH: Herbal medications
commonly used in the practice of rheumatology: mechanisms of
action, efficacy, and side effects. Semin Arthritis Rheum.
34:773–784. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chun SC, Jee SY, Lee SG, Park SJ, Lee JR
and Kim SC: Anti-inflammatory activity of the methanol extract of
moutan cortex in LPS-activated Raw264.7 cells. Evid Based
Complement Alternat Med. 4:327–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu M and Gu Z: Screening of bioactive
compounds from moutan cortex and their anti-inflammatory activities
in rat synoviocytes. Evid Based Complement Alternat Med. 6:57–63.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun SM: Bei Ji Qian Jin Yao Fang. 8. 1st
edition. People’s Medical Publishing Press; Beijing: pp. 166–167.
1982
|
|
21
|
Lai JN, Chen HJ, Chen CC, Lin JH, Hwang JS
and Wang JD: Duhuo jisheng tang for treating osteoarthritis of the
knee: a prospective clinical observation. Chin Med. 2:42007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng CS, XXJ, Ye HZ, Wu GW, Li XH, Huang
SP and Liu XX: Computational approaches for exploring the potential
synergy and polypharmacology of Duhuo Jisheng Decoction in the
therapy of osteoarthritis. Mol Med Report. 7:1812–1818.
2013.PubMed/NCBI
|
|
23
|
Wu G, Chen W, Fan H, et al: Duhuo Jisheng
Decoction promotes chondrocyte proliferation through accelerated
G1/S transition in osteoarthritis. Int J Mol Med. 32:1001–1010.
2013.PubMed/NCBI
|
|
24
|
Panico AM, Cardile V, Garufi F, Puglia C,
Bonina F and Ronsisvalle G: Effect of hyaluronic acid and
polysaccharides from Opuntia ficus indica (L.) cladodes on
the metabolism of human chondrocyte cultures. J Ethnopharmacol.
111:315–321. 2007.PubMed/NCBI
|
|
25
|
The Ministry of Science and Technology of
the People’s Republic of China. Guidance Suggestions for the Care
and Use of Laboratory Animals. 2006.
|
|
26
|
Huang J, Huang X, Chen Z, Zheng Q and Sun
R: Dose conversion among different animals and healthy volunteers
in pharmacological study. Chin J Clin Pharmacol Ther. 9:1069–1072.
2004.(In Chinese).
|
|
27
|
Li XH, Du M, Liu XX, et al: Millimeter
wave treatment inhibits NO-induced apoptosis of chondrocytes
through the p38MAPK pathway. Int J Mol Med. 25:393–399.
2010.PubMed/NCBI
|
|
28
|
Li XH, Wu MX, YHZ, Chen WL, Lin JM, Zheng
LP and Liu XX: Experimental study on the suppression of sodium
nitroprussiate-induced chondrocyte apoptosis by tougu xiaotong
capsule-containing serum. Chin J Integr Med. 17:436–443. 2011.(In
Chinese).
|
|
29
|
Sanchez C, Mathy-Hartert M, Deberg MA,
Ficheux H, Reginster JY and Henrotin YE: Effects of rhein on human
articular chondrocytes in alginate beads. Biochem Pharmacol.
65:377–388. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu SQ, Otero M, Unger FM, et al:
Anti-inflammatory activity of an ethanolic Caesalpinia
sappan extract in human chondrocytes and macrophages. J
Ethnopharmacol. 138:364–372. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mankin HJ: The response for articular
cartilage to mechanical injury. J Bone Joint Surg Am. 64:460–466.
1982.PubMed/NCBI
|
|
32
|
Brandt KD and Mazzuca SA: Lessons learned
from nine clinical trials of disease-modifying osteoarthritis
drugs. Arthritis Rheum. 52:3349–3359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bensky D, Gamble A and Stöger E: Chinese
Herbal Medicine: Materia Medica. 3rd edition. Eastland Press;
Seattle, WA: 2004
|
|
34
|
Ho LJ and Lai JH: Chinese herbs as
immunomodulators and potential disease-modifying antirheumatic
drugs in autoimmune disorders. Curr Drug Metab. 5:181–192. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tashino S: ‘Serum pharmacology’ and ‘serum
pharmaceutical chemistry’: from pharmacology of Chinese traditional
medicines to start a new measurement of drug concentration in
blood. Ther Drug Monit Res. 5:54–64. 1988.
|
|
36
|
Liu N, Liu JT, Ji YY and Lu PP: Dahuang
zhechong pill containing serum inhibited platelet-derived growth
factor-stimulated vascular smooth muscle cells proliferation by
inducing G1 arrest partly via suppressing protein kinase C
α-extracellular regulated kinase 1/2 signaling. Chin J Integr Med.
18:371–377. 2012.(In Chinese).
|
|
37
|
Dang XY, Dong L, Shi HT and Zou BC:
Effects of serum containing Chinese medicine Sanpi Pingwei formula
on proliferation and apoptosis of human SGC-7901 cells. Chin J
Integr Med. 19:119–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang WJ, Li DJ, Li J and Zhou WJ: An in
vitro study on neuroprotective effects of serum containing
Gengnianchun decoction and its main monomers against amyloid beta
protein-induced cellular toxicity. J Chin Integr Med. 8:67–73.
2010.(In Chinese).
|
|
39
|
Henrotin Y, Sanchez C and Reginster JY:
The inhibition of metalloproteinases to treat osteoarthritis:
reality and new perspectives. Expert Opin Ther Patents. 12:29–43.
2002. View Article : Google Scholar
|
|
40
|
Tetlow LC, Adlam DJ and Woolley DE: Matrix
metalloproteinase and proinflammatory cytokine production by
chondrocytes of human osteoarthritic cartilage. Arthritis Rheum.
44:585–594. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Martel-Pelletier J, Di Battista J and
Lajeunesse D: Biochemical factors in joint articular tissue
degradation in osteoarthritis. Osteoarthritis: Clinical and
Experimental Aspects. Reginster J-YL, Pelletier JP,
Martel-Pelletier J and Henrotin YE: Springer; Berlin: pp. 156–187.
1999, View Article : Google Scholar
|
|
42
|
Park K, Hoffmeister B, Han DK and Hasty K:
Therapeutic ultrasound effects on interleukin-1beta stimulated
cartilage construct in vitro. Ultrasound Med Biol. 33:286–295.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tan L, Peng H, Osaki M, Choy BK, Auron PE,
Sandell LJ and Goldring MB: Egr-1 mediates transcriptional
repression of COL2A1 promoter activity by interleukin-1beta. J Biol
Chem. 278:17688–17700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gibson SL, Dai CY, Lee HW, et al:
Inhibition of colon tumor progression and angiogenesis by the
Ink4a/Arf locus. Cancer Res. 63:742–746. 2003.PubMed/NCBI
|
|
45
|
Massagué J: G1 cell-cycle control and
cancer. Nature. 432:298–306. 2004.
|
|
46
|
Musgrove EA, Caldon CE, Barraclough J,
Stone A and Sutherland RL: Cyclin D as a therapeutic target in
cancer. Nat Rev Cancer. 11:558–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li J, Poi MJ and Tsai MD: Regulatory
mechanisms of tumor suppressor P16(INK4A) and their relevance to
cancer. Biochemistry. 50:5566–5582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Witkiewicz AK, Knudsen KE, Dicker AP and
Knudsen ES: The meaning of p16(ink4a) expression in tumors:
functional significance, clinical associations and future
developments. Cell Cycle. 10:2497–2503. 2011. View Article : Google Scholar : PubMed/NCBI
|
